ArticleBMC cancer2026

Severe anemia as a risk factor in Japanese patients with ovarian cancer receiving olaparib: a retrospective study.

Kenta Yamaoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.